Sinil Pharmaceutical Co., Ltd. (KOSDAQ:012790)
South Korea
· Delayed Price · Currency is KRW 5,990.00
-100.00 (-1.64%)
At close: Mar 9, 2026
Sinil Pharmaceutical Ratios and Metrics
Market cap in millions KRW. Fiscal year is January - December.
Millions KRW. Fiscal year is Jan - Dec.
Fiscal Year | Current | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 | 2019 - 2015 |
|---|---|---|---|---|---|---|---|
Period Ending | Mar '26 Mar 6, 2026 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 | Dec '20 Dec 31, 2020 | 2019 - 2015 |
| Market Capitalization | 68,144 | 73,149 | 87,711 | 96,840 | 128,314 | 247,300 | Upgrade
|
| Market Cap Growth | -8.55% | -16.60% | -9.43% | -24.53% | -48.11% | 229.18% | Upgrade
|
| Enterprise Value | 30,262 | 41,173 | 69,844 | 73,664 | 110,106 | 234,589 | Upgrade
|
| Last Close Price | 5990.00 | 6234.53 | 7257.77 | 7822.22 | 10237.90 | 19547.29 | Upgrade
|
| PE Ratio | 6.12 | 5.12 | 6.43 | 7.97 | 19.21 | 32.78 | Upgrade
|
| PS Ratio | 0.84 | 0.82 | 0.98 | 1.21 | 2.08 | 4.03 | Upgrade
|
| PB Ratio | 0.45 | 0.50 | 0.65 | 0.79 | 1.13 | 2.30 | Upgrade
|
| P/TBV Ratio | 0.45 | 0.51 | 0.66 | 0.80 | 1.15 | 2.33 | Upgrade
|
| P/FCF Ratio | 8.56 | 5.93 | 56.56 | 29.03 | 16.41 | 109.40 | Upgrade
|
| P/OCF Ratio | 5.14 | 3.22 | 5.79 | 7.08 | 11.50 | 22.36 | Upgrade
|
| EV/Sales Ratio | 0.37 | 0.46 | 0.78 | 0.92 | 1.78 | 3.82 | Upgrade
|
| EV/EBITDA Ratio | 1.59 | 1.98 | 3.61 | 4.07 | 8.80 | 21.22 | Upgrade
|
| EV/EBIT Ratio | 2.55 | 2.71 | 4.99 | 5.39 | 13.80 | 35.43 | Upgrade
|
| EV/FCF Ratio | 3.80 | 3.34 | 45.04 | 22.08 | 14.08 | 103.77 | Upgrade
|
| Debt / Equity Ratio | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | Upgrade
|
| Debt / EBITDA Ratio | 0.02 | 0.02 | 0.03 | 0.01 | 0.02 | 0.04 | Upgrade
|
| Debt / FCF Ratio | 0.04 | 0.04 | 0.35 | 0.04 | 0.04 | 0.17 | Upgrade
|
| Net Debt / Equity Ratio | -0.25 | -0.23 | -0.17 | -0.19 | -0.18 | -0.13 | Upgrade
|
| Net Debt / EBITDA Ratio | -1.99 | -1.60 | -1.18 | -1.28 | -1.64 | -1.28 | Upgrade
|
| Net Debt / FCF Ratio | -4.76 | -2.70 | -14.75 | -6.96 | -2.63 | -6.28 | Upgrade
|
| Asset Turnover | 0.49 | 0.56 | 0.60 | 0.59 | 0.49 | 0.51 | Upgrade
|
| Inventory Turnover | 1.95 | 2.15 | 2.42 | 2.40 | 2.22 | 2.33 | Upgrade
|
| Quick Ratio | 3.99 | 3.32 | 3.27 | 2.95 | 3.46 | 3.44 | Upgrade
|
| Current Ratio | 5.63 | 4.71 | 4.86 | 4.22 | 4.86 | 5.08 | Upgrade
|
| Return on Equity (ROE) | 7.67% | 10.16% | 10.57% | 10.28% | 6.05% | 7.23% | Upgrade
|
| Return on Assets (ROA) | 4.49% | 5.98% | 5.92% | 6.28% | 3.93% | 3.41% | Upgrade
|
| Return on Invested Capital (ROIC) | 8.94% | 11.69% | 12.04% | 11.77% | 6.88% | 6.75% | Upgrade
|
| Return on Capital Employed (ROCE) | 7.60% | 10.20% | 10.10% | 10.80% | 6.80% | 5.80% | Upgrade
|
| Earnings Yield | 16.60% | 19.55% | 15.55% | 12.55% | 5.21% | 3.05% | Upgrade
|
| FCF Yield | 11.68% | 16.85% | 1.77% | 3.45% | 6.09% | 0.91% | Upgrade
|
| Payout Ratio | 19.42% | 13.74% | 8.15% | 8.89% | 15.73% | 14.92% | Upgrade
|
| Buyback Yield / Dilution | 0.02% | 0.02% | -3.94% | 1.05% | 0.11% | 2.91% | Upgrade
|
Source: S&P Capital IQ. Standard template. Financial Sources.